🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT06804772
Active, not recruiting Not applicable

A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging, by Comparing to a Placebo

NCT06804772 · tracked via the Priya Life Science USA tracker
Sponsor
Victoria Collotta
Phase
Not applicable
Started
2024-12-03
Last updated
2025-02-03

Condition(s) studied

Skin Aging

Investigational drug(s) / intervention(s)

Investigational Facial Serum #3Investigational Facial Serum #1Investigational Facial Serum #2

Investigational Facial Serum #3: Investigational Facial Serum #3 is a placebo comparator

Investigational Facial Serum #1: Investigational Facial Serum #1 is made with Activated Silk™ 27P-α.

Investigational Facial Serum #2: Investigational Facial Serum #2 is made with an active comparator.

Study summary

A clinical study with approximately 15 subjects, aged 35-65 years of age, who must have crow's feet and at least one other type of facial fine lines/wrinkles in order to evaluate the efficacy of Activated Silk™ 27P-α to improve the signs of aging, by comparing to a placebo.

Eligibility

Sex
ALL
Min age
35 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Healthy individuals, between the ages of 35 - 65 years of age, with no known medical conditions that interfere with study participation, are the priority. * Subject has signed a written Informed Consent prior to Day -7. * 100% of subjects have crow's feet and at least one of the following: forehead lines/wrinkles (e.g. vertical lines between eyebrows, horizontal lines above the eyebrow), marionette lines, nasolabial folds. * 50% of subjects have self-perceived sensitive skin. * 20% of the subjects are not 100% Caucasian. Exclusion Criteria: * Subject is pregnant, nursing, or planning to become pregnant. * Subject is currently using medication likely to affect the response to investigational formulation. * Subject had a fever in the last 12 hours prior to the start of the study. * Subject has a pacemaker or significant medical history of hepatic, renal, cardiac, pulmonary, digestive, hematological, neurological, locomotor or psychiatric disease; cancer; multiple sclerosis; high blood pressure; thrombosis; phlebitis; insulin-dependent diabetes; or any such related medical condition(s) that may interfere with the completion of the study. * The Subject used a form of retinol on their face in the past six months. * The Subject used any prescription skincare products on their face in the last six months. * The Subject has received any laser, chemical peel, or other facial resurfacing treatment such as microdermabrasion, dermablading or microneedling in the past four weeks. * The Subject received Botox, Dysport, other muscle relaxers or injectable skin fillers in the face during the past six months. * Subject has a known allergy or sensitivity to any ingredient in the aqueous skincare formulation provided for their use in the trial . * Subject is currently participating in another study utilizing facial products. * Subject is blind, visually impaired or decisionally impaired.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Evolved By Nature Needham Massachusetts

More Victoria Collotta trials in the USA

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06804772 on ClinicalTrials.gov ↗ ← All trials in the USA